Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

IPSEN: Disclosure of Transactions in Own Shares between 10/12/2020 and 10/16/2020

10/20/2020 | 12:01pm EST

Regulatory News:

IPSEN:

Aggregated presentation by day and market

Issuer name Issuer identification code Transaction date Identification code of the
financial instrument

Daily total volume (in
number of shares)

Daily weighted
average price of
shares acquired

Platform
IPSEN 549300M6SGDPB4Z94P11 12/10/2020 FR0010259150

6,258

82.8688

XPAR
IPSEN 549300M6SGDPB4Z94P11 12/10/2020 FR0010259150

2,175

82.9733

CHIX
IPSEN 549300M6SGDPB4Z94P11 12/10/2020 FR0010259150

842

82.9002

TRQX
IPSEN 549300M6SGDPB4Z94P11 12/10/2020 FR0010259150

831

83.0221

BATE
IPSEN 549300M6SGDPB4Z94P11 13/10/2020 FR0010259150

14,917

81.4009

XPAR
IPSEN 549300M6SGDPB4Z94P11 14/10/2020 FR0010259150

633

80.8282

XPAR
IPSEN 549300M6SGDPB4Z94P11 14/10/2020 FR0010259150

554

80.81

CHIX
IPSEN 549300M6SGDPB4Z94P11 14/10/2020 FR0010259150

310

80.7450

TRQX
IPSEN 549300M6SGDPB4Z94P11 14/10/2020 FR0010259150

523

80.7828

BATE
IPSEN 549300M6SGDPB4Z94P11 15/10/2020 FR0010259150

29,106

78.1786

XPAR
IPSEN 549300M6SGDPB4Z94P11 16/10/2020 FR0010259150

6,699

78.6559

XPAR
IPSEN 549300M6SGDPB4Z94P11 16/10/2020 FR0010259150

2,705

78.3890

CHIX
IPSEN 549300M6SGDPB4Z94P11 16/10/2020 FR0010259150

1,074

78.3664

TRQX
IPSEN 549300M6SGDPB4Z94P11 16/10/2020 FR0010259150

3,144

79.0261

BATE
Total

69,771

79.7233

The information detailed by transaction and the buy-back objectives are available on the company's website at the following address: http://www.ipsen.com/investors/regulated-information/


© Business Wire 2020
All news about IPSEN
12/01IPSEN : receives FDA Fast Track designation for investigational irinotecan lipos..
AQ
12/01France's Ipsen plans $3.6 billion investment in drugs pipeline
RE
12/01IPSEN : new strategic priorities unveiled at virtual Capital Markets Day event
PU
12/01IPSEN : Highlights New Strategic Priorities and Provides Mid-Term Financial Outl..
BU
11/30IPSEN : receives FDA Fast Track designation for investigational irinotecan lipos..
PU
11/25EACD 2020 : How the use of functional assessments in clinical trials provides me..
PU
11/18ALERT : New purchases in the Investor Europe portfolio
10/27IPSEN : Disclosure of Transactions in Own Shares Between 10/19/2020 And 10/20/20..
BU
10/23IPSEN : delivers sales growth in the first nine months of 2020 despite the impac..
AQ
10/22IPSEN : Q3 2020 Sales Conference Call – Thursday, October 22, 2020
PU
More news
Financials
Sales 2020 2 636 M 3 203 M 3 203 M
Net income 2020 451 M 548 M 548 M
Net Debt 2020 749 M 911 M 911 M
P/E ratio 2020 12,9x
Yield 2020 1,49%
Capitalization 5 741 M 6 975 M 6 976 M
EV / Sales 2020 2,46x
EV / Sales 2021 2,15x
Nbr of Employees 5 807
Free-Float 42,0%
Chart IPSEN
Duration : Period :
Ipsen Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IPSEN
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 94,83 €
Last Close Price 69,50 €
Spread / Highest target 62,6%
Spread / Average Target 36,5%
Spread / Lowest Target 16,5%
EPS Revisions
Managers
NameTitle
David G. Loew Chief Executive Officer & Director
Marc M. P. de Garidel Non-Executive Chairman
Aymeric Le Chatelier Chief Financial Officer & Executive Vice President
Aidan Murphy Executive Vice President-Technical Operations
Howard Mayer Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IPSEN-8.99%7 175
JOHNSON & JOHNSON1.56%389 985
ROCHE HOLDING AG-3.61%289 019
PFIZER, INC.9.91%226 783
NOVARTIS AG-10.86%207 948
MERCK & CO., INC.-10.03%207 033